Desmoplakin disease in arrhythmogenic right ventricular cardiomyopathy: early genotype-phenotype studies
- PMID: 15941722
- DOI: 10.1093/eurheartj/ehi343
Desmoplakin disease in arrhythmogenic right ventricular cardiomyopathy: early genotype-phenotype studies
Comment on
-
Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations.Eur Heart J. 2005 Aug;26(16):1666-75. doi: 10.1093/eurheartj/ehi341. Epub 2005 Jun 7. Eur Heart J. 2005. PMID: 15941723
Similar articles
-
Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression.Circulation. 2007 Apr 3;115(13):1710-20. doi: 10.1161/CIRCULATIONAHA.106.660241. Epub 2007 Mar 19. Circulation. 2007. PMID: 17372169
-
Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype.Europace. 2014 Dec;16(12):1838-46. doi: 10.1093/europace/euu128. Epub 2014 Jun 17. Europace. 2014. PMID: 24938629
-
Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy.Circulation. 2005 Aug 2;112(5):636-42. doi: 10.1161/CIRCULATIONAHA.104.532234. Circulation. 2005. PMID: 16061754
-
The changing spectrum of arrhythmogenic (right ventricular) cardiomyopathy.Cell Tissue Res. 2012 May;348(2):319-23. doi: 10.1007/s00441-012-1402-z. Epub 2012 Apr 4. Cell Tissue Res. 2012. PMID: 22476658 Review.
-
Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy.Cardiovasc Pathol. 2004 Jul-Aug;13(4):185-94. doi: 10.1016/j.carpath.2004.03.609. Cardiovasc Pathol. 2004. PMID: 15210133 Review.
Cited by
-
Determined to Fail--the Role of Genetic Mechanisms in Heart Failure.Curr Heart Fail Rep. 2015 Oct;12(5):333-8. doi: 10.1007/s11897-015-0264-6. Curr Heart Fail Rep. 2015. PMID: 26233853 Review.
-
A novel variant in plakophilin-2 gene detected in a family with arrhythmogenic right ventricular cardiomyopathy.J Interv Card Electrophysiol. 2012 Jun;34(1):11-8. doi: 10.1007/s10840-011-9643-4. Epub 2011 Dec 15. J Interv Card Electrophysiol. 2012. PMID: 22170284
-
Arrhythmogenic substrate at the interventricular septum as a target site for radiofrequency catheter ablation of recurrent ventricular tachycardia in left dominant arrhythmogenic cardiomyopathy.BMC Cardiovasc Disord. 2015 Mar 10;15:18. doi: 10.1186/s12872-015-0010-8. BMC Cardiovasc Disord. 2015. PMID: 25887693 Free PMC article.
-
Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy.Front Cardiovasc Med. 2021 Oct 12;8:759119. doi: 10.3389/fcvm.2021.759119. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34712717 Free PMC article.
-
Emerging concepts in arrhythmogenic dilated cardiomyopathy.Heart Fail Rev. 2021 Sep;26(5):1219-1229. doi: 10.1007/s10741-020-09933-z. Heart Fail Rev. 2021. PMID: 32056050 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources